Literature DB >> 9571236

Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.

P Lorenz1, B F Baker, C F Bennett, D L Spector.   

Abstract

Antisense oligonucleotides are powerful tools for the in vivo regulation of gene expression. We have characterized the intracellular distribution of fluorescently tagged phosphorothioate oligodeoxynucleotides (PS-ONs) at high resolution under conditions in which PS-ONs have the potential to display antisense activity. Under these conditions PS-ONs predominantly localized to the cell nucleus where they accumulated in 20-30 bright spherical foci designated phosphorothioate bodies (PS bodies), which were set against a diffuse nucleoplasmic population excluding nucleoli. PS bodies are nuclear structures that formed in cells after PS-ON delivery by transfection agents or microinjection but were observed irrespectively of antisense activity or sequence. Ultrastructurally, PS bodies corresponded to electron-dense structures of 150-300 nm diameter and resembled nuclear bodies that were found with lower frequency in cells lacking PS-ONs. The environment of a living cell was required for the de novo formation of PS bodies, which occurred within minutes after the introduction of PS-ONs. PS bodies were stable entities that underwent noticeable reorganization only during mitosis. Upon exit from mitosis, PS bodies were assembled de novo from diffuse PS-ON pools in the daughter nuclei. In situ fractionation demonstrated an association of PS-ONs with the nuclear matrix. Taken together, our data provide evidence for the formation of a nuclear body in cells after introduction of phosphorothioate oligodeoxynucleotides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571236      PMCID: PMC25326          DOI: 10.1091/mbc.9.5.1007

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  70 in total

Review 1.  Advances in understanding the pharmacological properties of antisense oligonucleotides.

Authors:  S T Crooke
Journal:  Adv Pharmacol       Date:  1997

2.  Fluorescence microscopic comparison of the binding of phosphodiester and phosphorothioate (antisense) oligodeoxyribonucleotides to subcellular structures, including intermediate filaments, the endoplasmic reticulum, and the nuclear interior.

Authors:  R L Shoeman; R Hartig; Y Huang; S Grüb; P Traub
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-08

3.  Major internal nuclear matrix proteins are common to different human cell types.

Authors:  K A Mattern; R E van Goethem; L de Jong; R van Driel
Journal:  J Cell Biochem       Date:  1997-04       Impact factor: 4.429

Review 4.  Macromolecular domains within the cell nucleus.

Authors:  D L Spector
Journal:  Annu Rev Cell Biol       Date:  1993

5.  The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.

Authors:  J H Ahn; G S Hayward
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Ultrastructural immunolocalization of polyamines in HeLa cells subjected to fast-freezing fixation and freeze substitution.

Authors:  A M Roch; M T Nicolas; G Quash
Journal:  Histochem Cell Biol       Date:  1997-04       Impact factor: 4.304

7.  Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.

Authors:  D A Brown; S H Kang; S M Gryaznov; L DeDionisio; O Heidenreich; S Sullivan; X Xu; M I Nerenberg
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

8.  Potent and selective inhibition of gene expression by an antisense heptanucleotide.

Authors:  R W Wagner; M D Matteucci; D Grant; T Huang; B C Froehler
Journal:  Nat Biotechnol       Date:  1996-07       Impact factor: 54.908

9.  The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.

Authors:  M H Koken; F Puvion-Dutilleul; M C Guillemin; A Viron; G Linares-Cruz; N Stuurman; L de Jong; C Szostecki; F Calvo; C Chomienne
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

10.  Dynamic organization of DNA replication in mammalian cell nuclei: spatially and temporally defined replication of chromosome-specific alpha-satellite DNA sequences.

Authors:  R T O'Keefe; S C Henderson; D L Spector
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  24 in total

1.  Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.

Authors:  P Lorenz; T Misteli; B F Baker; C F Bennett; D L Spector
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Rapid, diffusional shuttling of poly(A) RNA between nuclear speckles and the nucleoplasm.

Authors:  Joan C Ritland Politz; Richard A Tuft; Kannanganattu V Prasanth; Nina Baudendistel; Kevin E Fogarty; Larry M Lifshitz; Jörg Langowski; David L Spector; Thoru Pederson
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

3.  Oligonucleotide therapies for disorders of the nervous system.

Authors:  Olga Khorkova; Claes Wahlestedt
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

4.  Minute virus of mice NS1 interacts with the SMN protein, and they colocalize in novel nuclear bodies induced by parvovirus infection.

Authors:  Philip J Young; Klaus T Jensen; Lisa R Burger; David J Pintel; Christian L Lorson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Uptake, cellular distribution and novel cellular binding proteins of immunostimulatory CpG oligodeoxynucleotides in glioblastoma cells.

Authors:  Zhiren Zhang; Toni Weinschenk; Hermann J Schluesener
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

6.  Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian Cells.

Authors:  Daniela Castanotto; Min Lin; Claudia Kowolik; Troels Koch; Bo Rode Hansen; Henrik Oerum; Cy A Stein
Journal:  Mol Ther       Date:  2016-03-10       Impact factor: 11.454

Review 7.  Antisense approach to inflammatory bowel disease: prospects and challenges.

Authors:  Irene Marafini; Davide Di Fusco; Emma Calabrese; Silvia Sedda; Francesco Pallone; Giovanni Monteleone
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

8.  Polymersome delivery of siRNA and antisense oligonucleotides.

Authors:  Younghoon Kim; Manorama Tewari; J David Pajerowski; Shenshen Cai; Shamik Sen; Jason H Williams; Jason Williams; Shashank R Sirsi; Shashank Sirsi; Gordon J Lutz; Gordon Lutz; Dennis E Discher
Journal:  J Control Release       Date:  2008-11-12       Impact factor: 9.776

Review 9.  Antisense oligonucleotides: treating neurodegeneration at the level of RNA.

Authors:  Sarah L DeVos; Timothy M Miller
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

10.  Use of a novel 5'-regioselective phosphitylating reagent for one-pot synthesis of nucleoside 5'-triphosphates from unprotected nucleosides.

Authors:  Julianne Caton-Williams; Rudiona Hoxhaj; Bilal Fiaz; Zhen Huang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.